Wang et al.31 have generated the FGF2 specific monoclonal antibody GAL-F2, which not only inhibits the proliferation and migration of HCC cells, but also blocks angiogenic signals in vivo, thus indicating the roles of FGF2 in tumor growth and angiogenesis. The gene discussed is FGF2; the disease is hepatocellular carcinoma.